partnerships corporate & business development corporate compliance & business practices pernix code of business conduct and ethics pernix compliance program and annual declaration locations products branded products treximet zohydro er silenor khedezla cedax generic products patient assistance program report an adverse event newsroom press releases events contacts investors overview stock information analyst coverage press releases events & presentations financials corporate governance investor contacts investor faqs careers join us our values benefits search jobs decisive in our actions learn about pernix values limitless in our energy learn about pernix values unified in our focus learn about pernix values responsive in our service learn about pernix values ethical in our efforts learn about pernix values unconstrained in our thinking learn about pernix values ptx nasdaq stock quote pernix therapeutics holdings incptx.o nasdaq 4.29 0.12 2.88 % oct 14 2016 4 00pm etdata provided by nasdaq . minimum 15 minutes delayed . upcoming events there are currently no events scheduled latest news october 13 2016pernix therapeutics announces reverse stock split and corporate governance enhancements read moreseptember 28 2016pernix therapeutics announces distribution of treximet 10 60 mg sumatriptan 10mg and naproxen sodium 60 mg dose for use in pediatric patients read moreseptember 16 2016marsha stanton ph.d. rn pernix therapeutics executive director of medical and government affairs awarded prestigious pain management advocacy award from the american society for pain management nursing read more copyright 2015 pernix therapeutics . all rights reserved.this information is intended only for residents of the united states . contact pernix terms of use privacy policy sitemap follow uslinkedin twitter rss